GlassScriptPhysician profile
John L Butsch
NPI 1396810172
$5,599.87
in general payments reported to CMS, 2019-2025
23 companies · $869 in 2025
The $869 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $1,119 · 2021: $233 · 2022: $550 · 2023: $702 · 2024: $1,819 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323 · Travel and Lodging: $1,059 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.91 |
| Travel and Lodging | $1,058.76 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,706.63 | 2019-2024 | Da Vinci Surgical System |
| Ethicon INC. | $875.00 | 2020 | |
| Next Science LLC | $572.45 | 2022-2023 | Xperience, Blastx, Surgx |
| Aop Health US, LLC | $542.44 | 2025 | Rapiblyk |
| Novo Nordisk INC | $267.33 | 2020-2025 | Wegovy |
| Medtronic, INC. | $230.15 | 2022-2025 | Ligasure, Progrip |
| Allergan, INC. | $211.46 | 2020-2022 | |
| Abbvie INC. | $189.36 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Activ Surgical, INC. | $186.00 | 2022 | |
| Ethicon US, LLC | $174.59 | 2019-2021 | |
| Medela LLC | $112.65 | 2022 | |
| Boston Scientific Corporation | $77.85 | 2023-2024 | Exalt Model D, Spyglass Discover |
| Conmed Corporation | $69.87 | 2019 | |
| Lilly USA, LLC | $67.16 | 2025 | Zepbound, Mounjaro |
| Smith+Nephew, INC. | $56.05 | 2022-2025 | Pico, Renasys Touch, Renasys Go V2 Home |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $55.85 | 2020-2024 | Progel Applicator Spray Tips |
| Covidien LP | $48.75 | 2019 | |
| Steris Corporation | $39.70 | 2024 | |
| Lucid Diagnostics INC. | $33.03 | 2022 | |
| Bolton Medical INC | $28.27 | 2025 | Gelweave |
| Misonix INC | $21.99 | 2021 | |
| Stryker Corporation | $20.17 | 2024 | Aim (Advanced Imaging Modality) |
| Mesh Suture INC | $13.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Butsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.